Buzzi M - Search Results

1

Induction of "in vitro" apoptosis by fludarabine in freshly isolated B-chronic lymphocytic leukemia cells.

Zinzani PL, Buzzi M, Farabegoli P, Tosi P, Fortuna A, Visani G, Martinelli G, Zaccaria A, Tura S. Zinzani PL, et al. Among authors: buzzi m. Leuk Lymphoma. 1994 Mar;13(1-2):95-7. doi: 10.3109/10428199409051657. Leuk Lymphoma. 1994. PMID: 8025527

2

Apoptosis induction with three nucleoside analogs on freshly isolated B-chronic lymphocytic leukemia cells.

Zinzani PL, Tosi P, Visani G, Martinelli G, Farabegoli P, Buzzi M, Ottaviani E, Salvucci M, Bendandi M, Zaccaria A, et al. Zinzani PL, et al. Among authors: buzzi m. Am J Hematol. 1994 Dec;47(4):301-6. doi: 10.1002/ajh.2830470410. Am J Hematol. 1994. PMID: 7977303

3

Apoptosis induction with fludarabine on freshly isolated chronic myeloid leukemia cells.

Zinzani PL, Buzzi M, Farabegoli P, Martinelli G, Tosi P, Zuffa E, Visani G, Testoni N, Salvucci M, Bendandi M, et al. Zinzani PL, et al. Among authors: buzzi m. Haematologica. 1994 Mar-Apr;79(2):127-31. Haematologica. 1994. PMID: 8063259

4

Structural organization of BCR-ABL gene in chronic phase and blast transformation in chronic myeloid leukemia patients.

Martinelli G, Zaccaria A, Farabegoli P, Buzzi M, Testoni N, Bragliani M, Panzica G, Tura S. Martinelli G, et al. Among authors: buzzi m. Leuk Lymphoma. 1993;11 Suppl 1:51-6. doi: 10.3109/10428199309047864. Leuk Lymphoma. 1993. PMID: 8251917

5

Will molecular biology contribute to refine prognosis and to select treatment? The Molecular Biology Committee. Italian Cooperative Study Group on Chronic Myeloid Leukemia.

Zaccaria A, Martinelli G, Buzzi M, Farabegoli P. Zaccaria A, et al. Among authors: buzzi m. Leuk Lymphoma. 1993;11 Suppl 1:81-9. doi: 10.3109/10428199309047869. Leuk Lymphoma. 1993. PMID: 8251923

6

Host origin of bone marrow fibroblasts following allogeneic bone marrow transplantation for chronic myeloid leukemia.

Santucci MA, Trabetti E, Martinelli G, Buzzi M, Zaccaria A, Pileri S, Farabegoli P, Sabattini E, Tura S, Pignatti PF. Santucci MA, et al. Among authors: buzzi m. Bone Marrow Transplant. 1992 Sep;10(3):255-9. Bone Marrow Transplant. 1992. PMID: 1422479

7

Reduced hematologic response to alpha-interferon therapy in patients with hairy cell leukemia showing a peculiar immunologic phenotype.

Lauria F, Raspadori D, Foa R, Zinzani PL, Buzzi M, Gugliotta L, Macchi S, Tura S. Lauria F, et al. Among authors: buzzi m. Cancer. 1990 May 15;65(10):2233-6. doi: 10.1002/1097-0142(19900515)65:10<2233::aid-cncr2820651012>3.0.co;2-k. Cancer. 1990. PMID: 1693308

8

Comparison of low-dose versus standard-dose alpha-interferon regimen in the hairy cell leukemia treatment.

Zinzani PL, Lauria F, Raspadori D, Buzzi M, Benfenati D, Bocchia M, Rondelli D, Tura S. Zinzani PL, et al. Among authors: buzzi m. Acta Haematol. 1991;85(1):16-9. doi: 10.1159/000204845. Acta Haematol. 1991. PMID: 2011924 Clinical Trial.

9

Cytogenetic events after bone marrow transplantation for Philadelphia chromosome positive chronic myeloid leukemia.

Zaccaria A, Rosti G, Testoni N, Santucci MA, Tassinari A, Celso B, Buzzi M, Miggiano MC, Tura S. Zaccaria A, et al. Among authors: buzzi m. Leuk Res. 1991;15(5):289-96. doi: 10.1016/0145-2126(91)90003-c. Leuk Res. 1991. PMID: 2046382 Review.

10

Relationship between immunological phenotype and hematological response to alpha-IFN treatment in 35 patients with hairy cell leukemia.

Lauria F, Zinzani PL, Raspadori D, Foà R, Buzzi M, Gugliotta L, Bocchia M, Benfenati D, Tura S. Lauria F, et al. Among authors: buzzi m. Eur J Haematol Suppl. 1990;52:3-6. doi: 10.1111/j.1600-0609.1990.tb00895.x. Eur J Haematol Suppl. 1990. PMID: 2279543

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

312 results

Search Page

Filters